Fresenius reports drug shortage; Lonza, Pharmacyclics extend their pact;

> The U.S. unit of Fresenius Kabi has reported a shortage of chloramphenicol sodium succinate injection to the FDA, citing a shortage of the active pharmaceutical ingredient. Report

> Germany-based Isarna Therapeutics has hired French drugmaker Sanofi ($SNY) to manufacture clinical- and commercial-grade antisense oligonucleotide (ASO) compounds for its development work. Release

> Switzerland-based contract manufacturer Lonza has extended a contract with Pharmacyclics ($PCYC) for the production of the biotech's cancer drug Imbruvica. Release

> Ampio Pharmaceuticals says it has started construction on a manufacturing facility in the Denver, CO, area for its drug candidate for prevalent inflammatory conditions. Release

And Finally... A Pakistani man living in Houston, TX, has pleaded guilty to charges that he imported from China 3,200 counterfeit Viagra and 4,000 counterfeit Cialis pills that he intended to sell. More